|
1
|
Siegel RL, Miller KD, Goding Sauer A,
Fedewa SA, Butterly LF, Anderson JC, Cercek A, Smith RA and Jemal
A: Colorectal cancer statistics, 2020. CA Cancer J Clin.
70:145–164. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2020. CA Cancer J Clin. 70:7–30. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Brody H: Colorectal cancer. Nature.
521:S12015. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Weitz J, Koch M, Debus J, Hohler T, Galle
PR and Buchler MW: Colorectal cancer. Lancet. 365:153–165. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Vatandoust S, Price TJ and Karapetis CS:
Colorectal cancer: Metastases to a single organ. World J
Gastroenterol. 21:11767–11776. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wrobel P and Ahmed S: Current status of
immunotherapy in metastatic colorectal cancer. Int J Colorectal
Dis. 34:13–25. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Park YS, Kim HS, Kim JH, Choi SH, Kim DS,
Ryoo ZY, Kim JY and Lee S: NAB2-STAT6 fusion protein mediates cell
proliferation and oncogenic progression via EGR-1 regulation.
Biochem Biophys Res Commun. 526:287–292. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yi L, Lyn YJ, Peng C, Zhu RL, Bai SS, Liu
L, Wang PX, Zhou H and Dong Y: Sinomenine inhibits fibroblast-like
synoviocyte proliferation by regulating α7nAChR expression via
ERK/Egr-1 pathway. Int Immunopharmacol. 56:65–70. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sun T, Tian H, Feng YG, Zhu YQ and Zhang
WQ: Egr-1 promotes cell proliferation and invasion by increasing
β-catenin expression in gastric cancer. Dig Dis Sci. 58:423–430.
2013.PubMed/NCBI
|
|
10
|
Lee BS, Kang S, Kim KA, Song YJ, Cheong
KH, Cha HY and Kim CH: Met degradation by SAIT301, a Met monoclonal
antibody, reduces the invasion and migration of nasopharyngeal
cancer cells via inhibition of EGR-1 expression. Cell Death Dis.
5:e11592014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu P, Li J, Lu H and Xu B: Thalidomide
inhibits leukemia cell invasion and migration by upregulation of
early growth response gene 1. Leuke Lymphoma. 50:109–113. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Skorokhod A, Bachmann J, Giese NA,
Martignoni ME and Krakowski-Roosen H: Real-imaging cDNA-AFLP
transcript profiling of pancreatic cancer patients: Egr-1 as a
potential key regulator of muscle cachexia. BMC Cancer. 12:2652012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kong Y, Yin J, Fu Y, Chen Y, Zhou Y and
Geng X: Suppression of Elk1 inhibits thyroid cancer progression by
mediating PTEN expression. Oncol Rep. 40:1769–1776. 2018.PubMed/NCBI
|
|
14
|
Kim SO, Kwon JI, Jeong YK, Kim GY, Kim ND
and Choi YH: Induction of Egr-1 is associated with anti-metastatic
and anti-invasive ability of beta-lapachone in human
hepatocarcinoma cells. Biosci Biotechnol Biochem. 71:2169–2176.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Calogero A, Porcellini A, Lombari V,
Fabbiano C, Arcella A, Miscusi M, Ponti D and Ragona G: Sensitivity
to cisplatin in primary cell lines derived from human glioma
correlates with levels of EGR-1 expression. Cancer Cell Int.
11:52011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Myung E, Park YL, Kim N, Chung CY, Park
HB, Park HC, Myung DS, Kim JS, Cho SB, Lee WS and Joo YE:
Expression of early growth response-1 in human gastric cancer and
its relationship with tumor cell behaviors and prognosis. Pathol
Res Pract. 209:692–699. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li TT, Liu MR and Pei DS: Friend or foe,
the role of EGR-1 in cancer. Med Oncol. 37:72019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sukhatme VP, Cao XM, Chang LC, Tsai-Morris
CH, Stamenkovich D, Ferreira PC, Cohen DR, Edwards SA, Shows TB,
Curran T, et al: A zinc finger-encoding gene coregulated with c-fos
during growth and differentiation, and after cellular
depolarization. Cell. 53:37–43. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Thiel G, Muller I and Rossler OG:
Expression, signaling and function of Egr transcription factors in
pancreatic β-cells and insulin-responsive tissues. Mol Cell
Endocrinol. 388:10–19. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kubosaki A, Tomaru Y, Tagami M, Arner E,
Miura H, Suzuki T, Suzuki M, Suzuki H and Hayashizaki Y:
Genome-wide investigation of in vivo EGR-1 binding sites in
monocytic differentiation. Genome Biol. 10:R412009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Thiel G and Cibelli G: Regulation of life
and death by the zinc finger transcription factor Egr-1. J Cell
Physiol. 193:287–292. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Silverman ES, Du J, Williams AJ,
Wadgaonkar R, Drazen JM and Collins T:
cAMP-response-element-binding-protein-binding protein (CBP) and
p300 are transcriptional co-activators of early growth response
factor-1 (Egr-1). Biochem J. 336:183–189. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Vo N and Goodman RH: CREB-binding protein
and p300 in transcriptional regulation. J Biol Chem.
276:13505–13508. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cartron PF, Blanquart C, Hervouet E,
Gregoire M and Vallette FM: HDAC1-mSin3a-NCOR1, Dnmt3b-HDAC1-Egr1
and Dnmt1-PCNA-UHRF1-G9a regulate the NY-ESO1 gene expression. Mol
Oncol. 7:452–463. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Meyerson M, Enders GH, Wu CL, Su LK, Gorka
C, Nelson C, Harlow E and Tsai LH: A family of human cdc2-related
protein kinases. EMBO J. 11:2909–2917. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yen SH, Kenessey A, Lee SC and Dickson DW:
The distribution and biochemical properties of a Cdc2-related
kinase, KKIALRE, in normal and Alzheimer brains. J Neurochem.
65:2577–2584. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tang L, Gao Y, Yan F and Tang J:
Evaluation of cyclin-dependent kinase-like 1 expression in breast
cancer tissues and its regulation in cancer cell growth. Cancer
Biother Radiopharm. 27:392–398. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sun W, Yao L, Jiang B, Shao H, Zhao Y and
Wang Q: A role for Cdkl1 in the development of gastric cancer. Acta
Oncol. 51:790–796. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Song Z, Lin J, Sun Z, Ni J and Sha Y:
RNAi-mediated downregulation of CDKL1 inhibits growth and
colony-formation ability, promotes apoptosis of human melanoma
cells. J Dermatol Sci. 79:57–63. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Qin C, Ren L, Ji M, Lv S, Wei Y, Zhu D,
Lin Q, Xu P, Chang W and Xu J: CDKL1 promotes tumor proliferation
and invasion in colorectal cancer. Onco Targets Ther. 10:1613–1624.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chandrashekar DS, Bashel B, Balasubramanya
SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK and
Varambally S: UALCAN: A portal for facilitating tumor subgroup gene
expression and survival analyses. Neoplasia. 19:649–658. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lee SH, Bahn JH, Choi CK, Whitlock NC,
English AE, Safe S and Baek SJ: ESE-1/EGR-1 pathway plays a role in
tolfenamic acid-induced apoptosis in colorectal cancer cells. Mol
Cancer Ther. 7:3739–3750. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Scharnhorst V, Menke AL, Attema J,
Haneveld JK, Riteco N, van Steenbrugge GJ, van der Eb AJ and
Jochemsen AG: EGR-1 enhances tumor growth and modulates the effect
of the Wilms' tumor 1 gene products on tumorigenicity. Oncogene.
19:791–800. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Myung DS, Park YL, Kim N, Chung CY, Park
HC, Kim JS, Cho SB, Lee WS, Lee JH and Joo YE: Expression of early
growth response-1 in colorectal cancer and its relation to tumor
cell proliferation and apoptosis. Oncol Rep. 31:788–794. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wei LL, Wu XJ, Gong CC and Pei DS: Egr-1
suppresses breast cancer cells proliferation by arresting cell
cycle progression via down-regulating CyclinDs. Int J Clin Exp
Pathol. 10:10212–10222. 2017.PubMed/NCBI
|
|
37
|
Ma Y, Ren Y and Guan J: Knockdown of GC
binding factor 2 by RNA interference inhibits invasion and
migration of vascular smooth muscle cells. Mol Med Rep.
20:1781–1789. 2019.PubMed/NCBI
|
|
38
|
Kou XX, Hao T, Meng Z, Zhou YH and Gan YH:
Acetylated Sp1 inhibits PTEN expression through binding to PTEN
core promoter and recruitment of HDAC1 and promotes cancer cell
migration and invasion. Carcinogenesis. 34:58–67. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Buttar NS, DeMars CJ, Lomberk G, Rizvi S,
Bonilla-Velez J, Achra S, Rashtak S, Wang KK, Fernandez-Zapico ME
and Urrutia R: Distinct role of Kruppel-like factor 11 in the
regulation of prostaglandin E2 biosynthesis. J Biol Chem.
285:11433–11444. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liu M, Wang X, Peng Y, Shen S and Li G:
Egr-1 regulates the transcription of NGX6 gene through a Sp1/Egr-1
overlapping site in the promoter. BMC Mol Biol. 15:142014.
View Article : Google Scholar : PubMed/NCBI
|
